Fabrication and Properties of Polycaprolactone Composites Containing Calcium Phosphate-Based Ceramics and Bioactive Glasses in Bone Tissue Engineering: A Review

Polymer Reviews

Volumn 58, Issue 1, 2018, Pages 164-207

  Hajiali, Faezeh ^a   Tajbakhsh, Saeid ^b   Shojaei, Akbar ^a  

^a SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

bioactive glasses; bone tissue engineering; calcium phosphate based ceramics; composite scaffolds; Polycaprolactone

Indexed keywords

BIOACTIVE GLASS; BIOCOMPATIBILITY; BIOMECHANICS; BONE; CALCIUM; CALCIUM COMPOUNDS; CALCIUM PHOSPHATE; CELL ADHESION; CELL ENGINEERING; CERAMIC MATERIALS; CONTROLLED DRUG DELIVERY; DEGRADATION; DRUG DELIVERY; FABRICATION; GLASS; MECHANICAL PROPERTIES; POLYCAPROLACTONE; POLYMERIC IMPLANTS; SCAFFOLDS (BIOLOGY); TISSUE;

BIOCOMPATIBLE POLYMER; BONE TISSUE ENGINEERING; COMPOSITE SCAFFOLDS; CONTROLLABLE DEGRADATION; CONTROLLED DRUG RELEASE; FABRICATION ROUTES; HYBRID BIOMATERIALS; PARTICULATE LEACHING;

TISSUE ENGINEERING;

EID: 85041424399     PISSN: 15583724     EISSN: 15583716     Source Type: Journal    
DOI: 10.1080/15583724.2017.1332640     Document Type: Review

References (278)

1. Holzwarth, J. M.,; Ma, P. X., “Biomimetic nanofibrous scaffolds for bone tissue engineering”, Biomaterials 2011, 32, 9622–9629.
2. Hutmacher, D. W., “Scaffolds in tissue engineering bone and cartilage”, Biomaterials 2000, 21, 2529–2543.
3. Agrawal, C.,; Ray, R. B., “Biodegradable polymeric scaffolds for musculoskeletal tissue engineering”, Journal of Biomedical Materials Research 2001, 55, 141–150.
4. Reis, R. L.,; Neves, N. M.,; Mano, J. F.,; Gomes, M. E.,; Marques, A. P.,; Azevedo, H. S., “Natural-Based Polymers for Biomedical Applications”; Elsevier, Amsterdam, 2008.
5. Hayashi, T., “Biodegradable polymers for biomedical uses”, Progress in Polymer Science 1994, 19, 663–702.
6. Sabir, M. I.,; Xu, X.,; Li, L., “A review on biodegradable polymeric materials for bone tissue engineering applications”, Journal of Materials Science 2009, 44, 5713–5724.
7. Fung, Y.-C., “Biomechanics: Mechanical Properties of Living Tissues”; Springer Science & Business Media, Berlin, 2013.
8. Rho, J.-Y.,; Kuhn-Spearing, L.,; Zioupos, P., “Mechanical properties and the hierarchical structure of bone”, Medical Engineering & Physics 1998, 20, 92–102.
9. Pal, S., “Design of Artificial Human Joints & Organs”; Springer, Berlin, 2014.
10. Ng, K. W.,; Hutmacher, D. W.,; Schantz, J.-T.,; Ng, C. S.,; Too, H.-P.,; Lim, T. C.,; Phan, T. T.,; Teoh, S. H., “Evaluation of ultra-thin poly (ϵ-caprolactone) films for tissue-engineered skin”, Tissue Engineering 2001, 7, 441–455.
11. Pitt, C. G., “Poly-ϵ-caprolactone and its copolymers”, Drugs and the Pharmaceutical Sciences 1990, 45, 71–120.
12. Cancedda, R.,; Dozin, B.,; Giannoni, P.,; Quarto, R., “Tissue engineering and cell therapy of cartilage and bone”, Matrix Biology 2003, 22, 81–91.
13. Gunatillake, P. A.,; Adhikari, R., “Biodegradable synthetic polymers for tissue engineering”, Eur Cell Mater. 2003, 5, 1–16.
14. Han, J.,; Branford-White, C. J.,; Zhu, L.-M., “Preparation of poly (ϵ-caprolactone)/poly (trimethylene carbonate) blend nanofibers by electrospinning”, Carbohydrate Polymers 2010, 79, 214–218.
15. Hench, L. L., “Bioceramics: From concept to clinic”, Journal of the American Ceramic Society 1991, 74, 1487–1510.
16. Puppi, D.,; Chiellini, F.,; Piras, A.,; Chiellini, E., “Polymeric materials for bone and cartilage repair”, Progress in Polymer Science 2010, 35, 403–440.
17. Kang, X.,; Xie, Y.,; Powell, H. M.,; Lee, L. J.,; Belury, M. A.,; Lannutti, J. J.,; Kniss, D. A., “Adipogenesis of murine embryonic stem cells in a three-dimensional culture system using electrospun polymer scaffolds”, Biomaterials 2007, 28, 450–458.
18. Place, E. S.,; George, J. H.,; Williams, C. K.,; Stevens, M. M., “Synthetic polymer scaffolds for tissue engineering”, Chemical Society Reviews 2009, 38, 1139–1151.
19. Causa, F.,; Netti, P.,; Ambrosio, L.,; Ciapetti, G.,; Baldini, N.,; Pagani, S.,; Martini, D.,; Giunti, A., “Poly-ε-caprolactone/hydroxyapatite composites for bone regeneration: In vitro characterization and human osteoblast response”, Journal of Biomedical Materials Research Part A 2006, 76, 151–162.
20. Yang, S.,; Leong, K.-F.,; Du, Z.,; Chua, C.-K., “The design of scaffolds for use in tissue engineering. Part I. Traditional factors”, Tissue Engineering 2001, 7, 679–689.
21. Coombes, A.,; Verderio, E.,; Shaw, B.,; Li, X.,; Griffin, M.,; Downes, S., “Biocomposites of non-crosslinked natural and synthetic polymers”, Biomaterials 2002, 23, 2113–2118.
22. Ghasemi-Mobarakeh, L.,; Prabhakaran, M. P.,; Morshed, M.,; Nasr-Esfahani, M.-H.,; Ramakrishna, S., “Electrospun poly (ϵ-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering”, Biomaterials 2008, 29, 4532–4539.
23. Annabi, N.,; Fathi, A.,; Mithieux, S. M.,; Martens, P.,; Weiss, A. S.,; Dehghani, F., “The effect of elastin on chondrocyte adhesion and proliferation on poly (ϵ-caprolactone)/elastin composites”, Biomaterials 2011, 32, 1517–1525.
24. Ciardelli, G.,; Chiono, V.,; Vozzi, G.,; Pracella, M.,; Ahluwalia, A.,; Barbani, N.,; Cristallini, C.,; Giusti, P., “Blends of poly-(ϵ-caprolactone) and polysaccharides in tissue engineering applications”, Biomacromolecules 2005, 6, 1961–1976.
25. Sarasam, A.,; Madihally, S. V., “Characterization of chitosan–polycaprolactone blends for tissue engineering applications”, Biomaterials 2005, 26, 5500–5508.
26. Hiljanen-Vainio, M.,; Karjalainen, T.,; Seppälä, J., “Biodegradable lactone copolymers. I. Characterization and mechanical behavior of ϵ-caprolactone and lactide copolymers”, Journal of Applied Polymer Science 1996, 59, 1281–1288.
27. Tajbakhsh, S.,; Hajiali, F., “A comprehensive study on the fabrication and properties of biocomposites of poly (lactic acid)/ceramics for bone tissue engineering”, Materials Science and Engineering C 2017, 70, 897–912.
28. Barralet, J. E.,; Wallace, L. L.,; Strain, A. J., “Tissue engineering of human biliary epithelial cells on polyglycolic acid/polycaprolactone scaffolds maintains long-term phenotypic stability”, Tissue Engineering 2003, 9, 1037–1045.
29. Kokubo, T.,; Takadama, H., “How useful is SBF in predicting in vivo bone bioactivity?”, Biomaterials 2006, 27, 2907–2915.
30. Maquet, V.,; Boccaccini, A. R.,; Pravata, L.,; Notingher, I.,; Jérôme, R., “Porous poly (α-hydroxyacid)/Bioglass® composite scaffolds for bone tissue engineering. I: preparation and in vitro characterisation”, Biomaterials 2004, 25, 4185–4194.
31. Wei, G.,; Ma, P. X., “Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering”, Biomaterials 2004, 25, 4749–4757.
32. Zhang, L.,; Webster, T. J., “Nanotechnology and nanomaterials: Promises for improved tissue regeneration”, Nano Today 2009, 4, 66–80.
33. Jarcho, M.,; Kay, J. F.,; Gumaer, K. I.,; Doremus, R. H.,; Drobeck, H. P., “Tissue, cellular and subcellular events at a bone-ceramic hydroxylapatite interface”, Journal of Bioengineering 1977, 1, 79–92.
34. Jarcho, M., “Calcium phosphate ceramics as hard tissue prosthetics”, Clinical Orthopaedics and Related Research 1981, 157, 259–278.
35. Hench, L. L.,; Splinter, R. J.,; Allen, W.,; Greenlee, T., “Bonding mechanisms at the interface of ceramic prosthetic materials”, Journal of Biomedical Materials Research 1971, 5, 117–141.
36. Daculsi, G.,; LeGeros, R.,; Heughebaert, M.,; Barbieux, I., “Formation of carbonate-apatite crystals after implantation of calcium phosphate ceramics”, Calcified Tissue International 1990, 46, 20–27.
37. Kokubo, T.,; Shigematsu, M.,; Nagashima, Y.,; Tashiro, M.,; Nakamura, T.,; Yamamuro, T.,; Higashi, S., “KURENAI: Kyoto University Research Information Repository”, Bull. Inst. Chem. Res., Kyoto Univ 1982, 60.
38. Hench, L. L.,; Wilson, J., An introduction to bioceramics; World Scientific, 1993, 41–74.
39. LeGeros, R. Z.,; Legeros, J. P., “Phosphate minerals in human tissues”, In Phosphate Minerals; Springer, Berlin, 1984, pp. 351–385.
40. Hristov, V.,; Radev, L.,; Samuneva, B.,; Apostolov, G., “Organic/inorganic bioactive materials Part I: Synthesis, structure and in vitro assessment of collagen/silicocarnotite biocoatings”, Central European Journal of Chemistry 2009, 7, 702–710.
41. Rezwan, K.,; Chen, Q.,; Blaker, J.,; Boccaccini, A. R., “Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering”, Biomaterials 2006, 27, 3413–3431.
42. Stevens, M. M., “Biomaterials for bone tissue engineering”, Materials Today 2008, 11, 18–25.
43. Shankar, R.,; Singh, D.,; Shaikh, S.,; Singh, G.,; Yadav, A.,; Jain, R., “Bone regeneration in osseous defects using hydroxyapatite graft and the extent of ossification in osseous defects treated without grafts: A comparative evaluation”, Journal of Maxillofacial and Oral Surgery 2011, 10, 123–126.
44. Liu, D.-M.,; Yang, Q.,; Troczynski, T.,; Tseng, W. J., “Structural evolution of sol–gel-derived hydroxyapatite”, Biomaterials 2002, 23, 1679–1687.
45. Kim, I.-S.,; Kumta, P. N., “Sol–gel synthesis and characterization of nanostructured hydroxyapatite powder”, Materials Science and Engineering B 2004, 111, 232–236.
46. Zakaria, S. M.,; Sharif Zein, S. H.,; Othman, M. R.,; Yang, F.,; Jansen, J. A., “Nanophase hydroxyapatite as a biomaterial in advanced hard tissue engineering: A review”, Tissue Engineering Part B: Reviews 2013, 19, 431–441.
47. Monmaturapoj, N., “Nano-size hydroxyapatite powders preparation by wet-chemical precipitation route”, Journal of Metals, Materials and Minerals 2008, 18, 15–20.
48. Liu, H.-S.,; Chin, T. S.,; Lai, L.,; Chiu, S.,; Chung, K.,; Chang, C.,; Lui, M., “Hydroxyapatite synthesized by a simplified hydrothermal method”, Ceramics International 1997, 23, 19–25.
49. Yoshimura, M.,; Suda, H.,; Okamoto, K.,; Ioku, K., “Hydrothermal synthesis of biocompatible whiskers”, Journal of Materials Science 1994, 29, 3399–3402.
50. Tas, A. C., “Synthesis of biomimetic Ca-hydroxyapatite powders at 37 C in synthetic body fluids”, Biomaterials 2000, 21, 1429–1438.
51. Ravaglioli, A.,; Krajewski, A., “Bioceramics: Materials, Properties, Applications”; Springer Science & Business Media, Berlin, 2012.
52. LeGeros, R. Z., “Properties of osteoconductive biomaterials: Calcium phosphates”, Clinical Orthopaedics and Related Research 2002, 395, 81–98.
53. Camiré, C.,; Jegou, S.-J. S.,; Hansen, S.,; McCarthy, I.,; Lidgren, L., “Hydration characteristics of alpha-tricalcium phosphates: Comparison of preparation routes”, Journal of Applied Biomaterials & Biomechanics 2004, 3, 106–111.
54. Jokic, B.,; Jankovic-Castvan, I.,; Veljovic, D.,; Bucevac, D.,; Obradovic-Djuricic, K.,; Petrovic, R.,; Janackovic, D., “Synthesis and settings behavior of α-TCP from calcium deficient hyroxyapatite obtained by hydrothermal method”, Journal of Optoelectronics and Advanced Materials 2007, 9, 1904–1910.
55. Famery, R.,; Richard, N.,; Boch, P., “Preparation of α-and β-tricalcium phosphate ceramics, with and without magnesium addition”, Ceramics International 1994, 20, 327–336.
56. Volkmer, T. M.,; Bastos, L.,; Sousa, V.,; Santos, L., “Obtainment of α-tricalcium phosphate by solution combustion synthesis method using urea as combustible”, In Key Engineering Materials; Trans Tech Publ, 2009, pp. 591–594.
57. Calandrelli, L.,; Immirzi, B.,; Malinconico, M.,; Luessenheide, S.,; Passaro, I.,; Di Pasquale, R.,; Oliva, A., “Natural and synthetic hydroxyapatite filled PCL: Mechanical properties and biocompatibility analysis”, Journal of Bioactive and Compatible Polymers 2004, 19, 301–313.
58. Bianco, P.,; Robey, P. G., “Stem cells in tissue engineering”, Nature 2001, 414, 118–121.
59. Pielichowska, K.,; Blazewicz, S., “Bioactive polymer/hydroxyapatite (nano) composites for bone tissue regeneration”, In Biopolymers; Springer, Berlin, 2010, pp. 97–207.
60. Huang, M.-N.,; Wang, Y.-L.,; Luo, Y.-F., “Biodegradable and bioactive porous polyurethanes scaffolds for bone tissue engineering”, Journal of Biomedical Science and Engineering 2009, 2, 36–40.
61. Hench, L. L., “Sol-gel materials for bioceramic applications”, Current Opinion in Solid State and Materials Science 1997, 2, 604–610.
62. Zhou, H.,; Lawrence, J. G.,; Bhaduri, S. B., “Fabrication aspects of PLA-CaP/PLGA-CaP composites for orthopedic applications: a review”, Acta Biomaterialia 2012, 8, 1999–2016.
63. Hench, L. L.,; Xynos, I. D.,; Polak, J. M., “Bioactive glasses for in situ tissue regeneration”, Journal of Biomaterials Science, Polymer Edition 2004, 15, 543–562.
64. Koutsopoulos, S., “Synthesis and characterization of hydroxyapatite crystals: A review study on the analytical methods”, Journal of Biomedical Materials Research 2002, 62, 600–612.
65. Hench, L. L., “Bioactive glasses and glass-ceramics”, In Materials Science Forum; Trans Tech Publ, 1999, pp. 37–64.
66. Carrodeguas, R. G.,; De Aza, S., “α-Tricalcium phosphate: synthesis, properties and biomedical applications”, Acta Biomaterialia 2011, 7, 3536–3546.
67. Liang, L.,; Rulis, P.,; Ching, W., “Mechanical properties, electronic structure and bonding of α-and β-tricalcium phosphates with surface characterization”, Acta Biomaterialia 2010, 6, 3763–3771.
68. Tanaka, H.,; Yasukawa, A.,; Kandori, K.,; Ishikawa, T., “Surface modification of calcium hydroxyapatite with hexyl and decyl phosphates”, Colloids and Surfaces A: Physicochemical and Engineering Aspects 1997, 125, 53–62.
69. Dupraz, A.,; De Wijn, J.,; De Groot, K., “Characterization of silane-treated hydroxyapatite powders for use as filler in biodegradable composites”, Journal of Biomedical Materials Research 1996, 30, 231–238.
70. Li, Y.,; Weng, W., “Surface modification of hydroxyapatite by stearic acid: Characterization and in vitro behaviors”, Journal of Materials Science: Materials in Medicine 2008, 19, 19–25.
71. Borum-Nicholas, L.,; Wilson, O., “Surface modification of hydroxyapatite. Part I. Dodecyl alcohol”, Biomaterials 2003, 24, 3671–3679.
72. Choi, H. W.,; Lee, H. J.,; Kim, K. J.,; Kim, H.-M.,; Lee, S. C., “Surface modification of hydroxyapatite nanocrystals by grafting polymers containing phosphonic acid groups”, Journal of Colloid and Interface Science 2006, 304, 277–281.
73. Liu, Q.,; De Wijn, J. R.,; Bakker, D.,; Van Blitterswijk, C. A., “Surface modification of hydroxyapatite to introduce interfacial bonding with polyactiveTM 70/30 in a biodegradable composite”, Journal of Materials Science: Materials in Medicine 1996, 7, 551–557.
74. El-Ghannam, A.,; Ducheyne, P.,; Shapiro, I., “Effect of serum proteins on osteoblast adhesion to surface-modified bioactive glass and hydroxyapatite”, Journal of Orthopaedic Research 1999, 17, 340–345.
75. Wilson, O. C.,; Hull, J. R., “Surface modification of nanophase hydroxyapatite with chitosan”, Materials Science and Engineering: C 2008, 28, 434–437.
76. Liao, J.-G.,; Wang, X.-J.,; Zuo, Y., “Surface modification of nano-hydroxyapatite with silane agent”, Journal of Inorganic Materials-Beijing 2008, 23, 145–149.
77. Durrieu, M.-C.,; Pallu, S.,; Guillemot, F.,; Bareille, R.,; Amédée, J.,; Baquey, C.,; Labrugère, C.,; Dard, M., “Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion”, Journal of Materials Science: Materials in Medicine 2004, 15, 779–786.
78. Ma, Z.,; Wang, J.,; Zhang, X., “Effect of silane KH-550 to polypropylene/brucite composite”, Journal of Applied Polymer Science 2008, 107, 1000–1005.
79. Norton, J.,; Malik, K.,; Darr, J.,; Rehman, I., “Recent developments in processing and surface modification of hydroxyapatite”, Advances in Applied Ceramics 2006, 105, 113–139.
80. Kim, H. W., “Biomedical nanocomposites of hydroxyapatite/polycaprolactone obtained by surfactant mediation”, Journal of Biomedical Materials Research Part A 2007, 83, 169–177.
81. Karlinsey, R. L.,; Mackey, A. C.,; Walker, E. R.,; Frederick, K. E., “Preparation, characterization and in vitro efficacy of an acid-modified β-TCP material for dental hard-tissue remineralization”, Acta Biomaterialia 2010, 6, 969–978.
82. Fan, R.,; Deng, X.,; Zhou, L.,; Gao, X.,; Fan, M.,; Wang, Y.,; Guo, G., “Injectable thermosensitive hydrogel composite with surface-functionalized calcium phosphate as raw materials”, International Journal of Nanomedicine 2014, 9, 615–626.
83. Lee, J. S.,; Murphy, W. L., “Functionalizing calcium phosphate biomaterials with antibacterial silver particles”, Advanced Materials 2013, 25, 1173–1179.
84. Zhou, H.,; Lee, J., “Nanoscale hydroxyapatite particles for bone tissue engineering”, Acta Biomaterialia 2011, 7, 2769–2781.
85. Matsumoto, T.,; Okazaki, M.,; Inoue, M.,; Yamaguchi, S.,; Kusunose, T.,; Toyonaga, T.,; Hamada, Y.,; Takahashi, J., “Hydroxyapatite particles as a controlled release carrier of protein”, Biomaterials 2004, 25, 3807–3812.
86. Mielczarek, A.,; Michalik, J., “The effect of nano-hydroxyapatite toothpaste on enamel surface remineralization. An in vitro study”, American Journal of Dentistry 2014, 27, 287–290.
87. Ong, J. L.,; Chan, D. C., “Hydroxyapatite and their use as coatings in dental implants: A review”, Critical Reviews™ in Biomedical Engineering 2000, 28, 667–707.
88. Gauthier, O.,; Goyenvalle, E.,; Bouler, J.-M.,; Guicheux, J.,; Pilet, P.,; Weiss, P.,; Daculsi, G., “Macroporous biphasic calcium phosphate ceramics versus injectable bone substitute: A comparative study 3 and 8 weeks after implantation in rabbit bone”, Journal of Materials Science: Materials in Medicine 2001, 12, 385–390.
89. Kaur, G.,; Pandey, O.,; Singh, K., “Interfacial study between high temperature SiO 2–B 2 O 3–AO–La 2 O 3 (A = Sr, Ba) glass seals and Crofer 22APU for solid oxide fuel cell applications”, International Journal of Hydrogen Energy 2012, 37, 6862–6874.
90. Kaur, G.,; Pandey, O. P.,; Singh, K.,; Homa, D.,; Scott, B.,; Pickrell, G., “A review of bioactive glasses: Their structure, properties, fabrication and apatite formation”, Journal of Biomedical Materials Research Part A 2014, 102, 254–274.
91. Li, R.,; Clark, A.,; Hench, L., “An investigation of bioactive glass powders by sol-gel processing”, Journal of Applied Biomaterials 1991, 2, 231–239.
92. Vichery, C.,; Nedelec, J.-M., “Bioactive Glass Nanoparticles: From Synthesis to Materials Design for Biomedical Applications”, Materials 2016, 9, 1–17.
93. Rahaman, M. N.,; Day, D. E.,; Bal, B. S.,; Fu, Q.,; Jung, S. B.,; Bonewald, L. F.,; Tomsia, A. P., “Bioactive glass in tissue engineering”, Acta Biomaterialia 2011, 7, 2355–2373.
94. Lobel, K.,; Hench, L., “In-vitro protein interactions with a bioactive gel-glass”, Journal of Sol-Gel Science and Technology 1996, 7, 69–76.
95. Ohgushi, H.,; Dohi, Y.,; Yoshikawa, T.,; Tamai, S.,; Tabata, S.,; Okunaga, K.,; Shibuya, T., “Osteogenic differentiation of cultured marrow stromal stem cells on the surface of bioactive glass ceramics”, Journal of Biomedical Materials Research 1996, 32, 341–348.
96. Hench, L. L., “Biomaterials: A forecast for the future”, Biomaterials 1998, 19, 1419–1423.
97. Wheeler, D.,; Stokes, K.,; Park, H.,; Hollinger, J., “Evaluation of particulate Bioglass® in a rabbit radius ostectomy model”, Journal of Biomedical Materials Research 1997, 35, 249–254.
98. Wheeler, D.,; Stokes, K.,; Hoellrich, R.,; Chamberland, D.,; McLoughlin, S., “Effect of bioactive glass particle size on osseous regeneration of cancellous defects”, Journal of Biomedical Materials Research 1998, 41, 527–533.
99. Salih, V.,; Franks, K.,; James, M.,; Hastings, G.,; Knowles, J.,; Olsen, I., “Development of soluble glasses for biomedical use Part II: The biological response of human osteoblast cell lines to phosphate-based soluble glasses”, Journal of Materials Science: Materials in Medicine 2000, 11, 615–620.
100. Uo, M.,; Mizuno, M.,; Kuboki, Y.,; Makishima, A.,; Watari, F., “Properties and cytotoxicity of water soluble Na 2 O–CaO–P 2 O 5 glasses”, Biomaterials 1998, 19, 2277–2284.
101. Ahmed, I.,; Lewis, M.,; Olsen, I.,; Knowles, J., “Phosphate glasses for tissue engineering: part 2. Processing and characterisation of a ternary-based P 2 O 5–CaO–Na 2 O glass fibre system”, Biomaterials 2004, 25, 501–507.
102. Renno, A. C. M.,; Bossini, P. S.,; Crovace, M. C.,; Rodrigues, A. C. M.,; Zanotto, E. D.,; Parizotto, N. A., “Characterization and in vivo biological performance of biosilicate”, BioMed Research International 2013, 1–7
103. Liu, A.,; Hong, Z.,; Zhuang, X.,; Chen, X.,; Cui, Y.,; Liu, Y.,; Jing, X., “Surface modification of bioactive glass nanoparticles and the mechanical and biological properties of poly (L-lactide) composites”, Acta Biomaterialia 2008, 4, 1005–1015.
104. Qiu, X.,; Hong, Z.,; Hu, J.,; Chen, L.,; Chen, X.,; Jing, X., “Hydroxyapatite surface modified by L-lactic acid and its subsequent grafting polymerization of L-lactide”, Biomacromolecules 2005, 6, 1193–1199.
105. Gao, Y.,; Chang, J., “Surface modification of bioactive glasses and preparation of PDLLA/bioactive glass composite films”, Journal of Biomaterials Applications 2008, 119–138.
106. El-Ghannam, A.,; Ducheyne, P.,; Shapiro, I., “Formation of surface reaction products on bioactive glass and their effects on the expression of the osteoblastic phenotype and the deposition of mineralized extracellular matrix”, Biomaterials 1997, 18, 295–303.
107. Chen, Q.,; Rezwan, K.,; Armitage, D.,; Nazhat, S.,; Boccaccini, A., “The surface functionalization of 45S5 Bioglass®-based glass-ceramic scaffolds and its impact on bioactivity”, Journal of Materials Science: Materials in Medicine 2006, 17, 979–987.
108. Verné, E.,; Vitale-Brovarone, C.,; Bui, E.,; Bianchi, C.,; Boccaccini, A., “Surface functionalization of bioactive glasses”, Journal of Biomedical Materials Research Part A 2009, 90, 981–992.
109. Haimi, S.,; Moimas, L.,; Pirhonen, E.,; Lindroos, B.,; Huhtala, H.,; Räty, S.,; Kuokkanen, H.,; Sándor, G. K.,; Miettinen, S.,; Suuronen, R., “Calcium phosphate surface treatment of bioactive glass causes a delay in early osteogenic differentiation of adipose stem cells”, Journal of Biomedical Materials Research Part A 2009, 91, 540–547.
110. Rahaman, M. N.,; Brown, R. F.,; Bal, B. S.,; Day, D. E., “Bioactive glasses for nonbearing applications in total joint replacement”, In Seminars in Arthroplasty; Elsevier, Amsterdam, 2006, pp. 102–112.
111. Hench, L. L.,; Wilson, J., “Surface-active Biomaterials”, Science 1984, 226, 630–636.
112. Jones, J. R., “Review of bioactive glass: from Hench to hybrids”, Acta Biomaterialia 2013, 9, 4457–4486.
113. Gomez-Vega, J. M.,; Saiz, E.,; Tomsia, A. P.,; Oku, T.,; Suganuma, K.,; Marshall, G. W.,; Marshall, S. J., “Novel bioactive functionally graded coatings on Ti6Al4V”, Advanced Materials 2000, 12, 894–898.
114. Tanner, K., “Bioactive composites for bone tissue engineering”, Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 2010, 224, 1359–1372.
115. Thomas, V.,; Jagani, S.,; Johnson, K.,; Jose, M. V.,; Dean, D. R.,; Vohra, Y. K.,; Nyairo, E., “Electrospun bioactive nanocomposite scaffolds of polycaprolactone and nanohydroxyapatite for bone tissue engineering”, Journal of Nanoscience and Nanotechnology 2006, 6, 487–493.
116. Li, D.,; Xia, Y., “Direct fabrication of composite and ceramic hollow nanofibers by electrospinning”, Nano Letters 2004, 4, 933–938.
117. Yang, F.,; Both, S. K.,; Yang, X.,; Walboomers, X. F.,; Jansen, J. A., “Development of an electrospun nano-apatite/PCL composite membrane for GTR/GBR application”, Acta Biomaterialia 2009, 5, 3295–3304.
118. Liao, S.,; Cui, F.,; Zhang, W.,; Feng, Q., “Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA composite”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2004, 69, 158–165.
119. Hutmacher, D. W.,; Sittinger, M.,; Risbud, M. V., “Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems”, Trends in Biotechnology 2004, 22, 354–362.
120. Simpson, R. L.,; Wiria, F. E.,; Amis, A. A.,; Chua, C. K.,; Leong, K. F.,; Hansen, U. N.,; Chandrasekaran, M.,; Lee, M. W., “Development of a 95/5 poly (L-lactide-co-glycolide)/hydroxylapatite and β-tricalcium phosphate scaffold as bone replacement material via selective laser sintering”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2008, 84, 17–25.
121. Yang, S.,; Leong, K.-F.,; Du, Z.,; Chua, C.-K., “The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques”, Tissue Engineering 2002, 8, 1–11.
122. Tan, K.,; Chua, C.,; Leong, K.,; Cheah, C.,; Gui, W.,; Tan, W.,; Wiria, F., “Selective laser sintering of biocompatible polymers for applications in tissue engineering”, Biomedical Materials and Engineering 2005, 15, 113–124.
123. Thomson, R. C.,; Yaszemski, M. J.,; Powers, J. M.,; Mikos, A. G., “Hydroxyapatite fiber reinforced poly (α-hydroxy ester) foams for bone regeneration”, Biomaterials 1998, 19, 1935–1943.
124. Ciapetti, G.,; Ambrosio, L.,; Savarino, L.,; Granchi, D.,; Cenni, E.,; Baldini, N.,; Pagani, S.,; Guizzardi, S.,; Causa, F.,; Giunti, A., “Osteoblast growth and function in porous poly ϵ-caprolactone matrices for bone repair: A preliminary study”, Biomaterials 2003, 24, 3815–3824.
125. Pielichowska, K., “Preparation of polyoxymethylene/hydroxyapatite nanocomposites by melt processing”, International Journal of Material Forming 2008, 1, 941–944.
126. Whang, K.,; Thomas, C.,; Healy, K.,; Nuber, G., “A novel method to fabricate bioabsorbable scaffolds”, Polymer 1995, 36, 837–842.
127. Harris, L. D.,; Kim, B.-S.,; Mooney, D. J., “Open pore biodegradable matrices formed with gas foaming”, Journal of Biomedical Materials Research 1998, 42, 396–402.
128. Nam, Y. S.,; Park, T. G., “Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation”, Journal of Biomedical Materials Research 1999, 47, 8–17.
129. Catledge, S.,; Clem, W.,; Shrikishen, N.,; Chowdhury, S.,; Stanishevsky, A.,; Koopman, M.,; Vohra, Y., “An electrospun triphasic nanofibrous scaffold for bone tissue engineering”, Biomedical Materials 2007, 2, 142–150.
130. Jaiswal, A.,; Chhabra, H.,; Soni, V.,; Bellare, J., “Enhanced mechanical strength and biocompatibility of electrospun polycaprolactone-gelatin scaffold with surface deposited nano-hydroxyapatite”, Materials Science and Engineering: C 2013, 33, 2376–2385.
131. Chuenjitkuntaworn, B.,; Inrung, W.,; Damrongsri, D.,; Mekaapiruk, K.,; Supaphol, P.,; Pavasant, P., “Polycaprolactone/hydroxyapatite composite scaffolds: Preparation, characterization, and in vitro and in vivo biological responses of human primary bone cells”, Journal of Biomedical Materials Research Part A 2010, 94, 241–251.
132. Johari, N.,; Fathi, M. H.,; Golozar, M. A., “The effect of fluorine content on the mechanical properties of poly (ϵ-caprolactone)/nano-fluoridated hydroxyapatite scaffold for bone-tissue engineering”, Ceramics International 2011, 37, 3247–3251.
133. Verma, D.,; Katti, K.,; Katti, D., “Experimental investigation of interfaces in hydroxyapatite/polyacrylic acid/polycaprolactone composites using photoacoustic FTIR spectroscopy”, Journal of Biomedical Materials Research Part A 2006, 77, 59–66.
134. Huang, L.-Y.,; Xu, K.-W.,; Lu, J., “A study of the process and kinetics of electrochemical deposition and the hydrothermal synthesis of hydroxyapatite coatings”, Journal of Materials Science: Materials in Medicine 2000, 11, 667–673.
135. Fabbri, P.,; Bondioli, F.,; Messori, M.,; Bartoli, C.,; Dinucci, D.,; Chiellini, F., “Porous scaffolds of polycaprolactone reinforced with in situ generated hydroxyapatite for bone tissue engineering”, Journal of Materials Science: Materials in Medicine 2010, 21, 343–351.
136. Rezaei, A.,; Mohammadi, M., “In vitro study of hydroxyapatite/polycaprolactone (HA/PCL) nanocomposite synthesized by an in situ sol–gel process”, Materials Science and Engineering: C 2013, 33, 390–396.
137. Sultana, N.,; Hayat Khan, T., “Polycaprolactone scaffolds and hydroxyapatite/polycaprolactone composite scaffolds for bone tissue engineering”, Journal of Bionanoscience 2013, 7, 169–173.
138. Yang, Y.,; Zhao, J.,; Zhao, Y.,; Wen, L.,; Yuan, X.,; Fan, Y., “Formation of porous PLGA scaffolds by a combining method of thermally induced phase separation and porogen leaching”, Journal of Applied Polymer Science 2008, 109, 1232–1241.
139. Nichols, H. L.,; Zhang, N.,; Zhang, J.,; Shi, D.,; Bhaduri, S.,; Wen, X., “Coating nanothickness degradable films on nanocrystalline hydroxyapatite particles to improve the bonding strength between nanohydroxyapatite and degradable polymer matrix”, Journal of Biomedical Materials Research Part A 2007, 82, 373–382.
140. Gong, X.-H.,; Tang, C.-Y.,; Hu, H.-C.,; Zhou, X.-P.,; Xie, X.-L., “Improved mechanical properties of HIPS/hydroxyapatite composites by surface modification of hydroxyapatite via in-situ polymerization of styrene”, Journal of Materials Science: Materials in Medicine 2004, 15, 1141–1146.
141. Tanaka, H.,; Futaoka, M.,; Hino, R.,; Kandori, K.,; Ishikawa, T., “Structure of synthetic calcium hydroxyapatite particles modified with pyrophosphoric acid”, Journal of Colloid and Interface Science 2005, 283, 609–612.
142. Wang, Y.,; Dai, J.,; Zhang, Q.,; Xiao, Y.,; Lang, M., “Improved mechanical properties of hydroxyapatite/poly (ϵ-caprolactone) scaffolds by surface modification of hydroxyapatite”, Applied Surface Science 2010, 256, 6107–6112.
143. Azevedo, M.,; Reis, R.,; Claase, M.,; Grijpma, D.,; Feijen, J., “Development and properties of polycaprolactone/hydroxyapatite composite biomaterials”, Journal of Materials Science: Materials in Medicine 2003, 14, 103–107.
144. Lee, H. J.,; Choi, H. W.,; Kim, K. J.,; Lee, S. C., “Modification of hydroxyapatite nanosurfaces for enhanced colloidal stability and improved interfacial adhesion in nanocomposites”, Chemistry of Materials 2006, 18, 5111–5118.
145. Lee, H. J.,; Kim, S. E.,; Choi, H. W.,; Kim, C. W.,; Kim, K. J.,; Lee, S. C., “The effect of surface-modified nano-hydroxyapatite on biocompatibility of poly (ϵ-caprolactone)/hydroxyapatite nanocomposites”, European Polymer Journal 2007, 43, 1602–1608.
146. Shor, L.,; Güçeri, S.,; Wen, X.,; Gandhi, M.,; Sun, W., “Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro”, Biomaterials 2007, 28, 5291–5297.
147. Heo, S.-J.,; Kim, S.-E.,; Wei, J.,; Kim, D. H.,; Hyun, Y.-T.,; Yun, H.-S.,; Kim, H. K.,; Yoon, T. R.,; Kim, S.-H.,; Park, S.-A., “In vitro and animal study of novel nano-hydroxyapatite/poly (ϵ-caprolactone) composite scaffolds fabricated by layer manufacturing process”, Tissue Engineering Part A 2008, 15, 977–989.
148. Heo, S. J.,; Kim, S. E.,; Wei, J.,; Hyun, Y. T.,; Yun, H. S.,; Kim, D. H.,; Shin, J. W.,; Shin, J. W., “Fabrication and characterization of novel nano-and micro-HA/PCL composite scaffolds using a modified rapid prototyping process”, Journal of Biomedical Materials Research Part A 2009, 89, 108–116.
149. Kim, H.-W.,; Knowles, J. C.,; Kim, H.-E., “Hydroxyapatite/poly (ϵ-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery”, Biomaterials 2004, 25, 1279–1287.
150. Zhao, J.,; Duan, K.,; Zhang, J.,; Lu, X.,; Weng, J., “The influence of polymer concentrations on the structure and mechanical properties of porous polycaprolactone-coated hydroxyapatite scaffolds”, Applied Surface Science 2010, 256, 4586–4590.
151. Wutticharoenmongkol, P.,; Sanchavanakit, N.,; Pavasant, P.,; Supaphol, P., “Preparation and characterization of novel bone scaffolds based on electrospun polycaprolactone fibers filled with nanoparticles”, Macromolecular Bioscience 2006, 6, 70–77.
152. Wutticharoenmongkol, P.,; Sanchavanakit, N.,; Pavasant, P.,; Supaphol, P., “Novel bone scaffolds of electrospun polycaprolactone fibers filled with nanoparticles”, Journal of Nanoscience and Nanotechnology 2006, 6, 514–522.
153. Wutticharoenmongkol, P.,; Pavasant, P.,; Supaphol, P., “Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles”, Biomacromolecules 2007, 8, 2602–2610.
154. Venugopal, J.,; Vadgama, P.,; Kumar, T. S.,; Ramakrishna, S., “Biocomposite nanofibres and osteoblasts for bone tissue engineering”, Nanotechnology 2007, 18, 055101.
155. Zhang, Y.,; Ouyang, H.,; Lim, C. T.,; Ramakrishna, S.,; Huang, Z. M., “Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2005, 72, 156–165.
156. Ashokan, A.,; Menon, D.,; Nair, S.,; Koyakutty, M., “A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent”, Biomaterials 2010, 31, 2606–2616.
157. Ganesh, N.,; Ashokan, A.,; Rajeshkannan, R.,; Chennazhi, K.,; Koyakutty, M.,; Nair, S., “MR functional nano-hydroxyapatite incorporated PCL composite scaffolds for in situ monitoring of bone tissue regeneration by MRI”, Tissue Eng Part A 2014, 20, 2783–2794.
158. Lebourg, M.,; Serra, R. S.,; Estellés, J. M.,; Sánchez, F. H.,; Ribelles, J. G.,; Antón, J. S., “Biodegradable polycaprolactone scaffold with controlled porosity obtained by modified particle-leaching technique”, Journal of Materials Science: Materials in Medicine 2008, 19, 2047–2053.
159. Marra, K. G.,; Szem, J. W.,; Kumta, P. N.,; DiMilla, P. A.,; Weiss, L. E., “In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering”, Journal of Biomedical Materials Research 1999, 47, 324–335.
160. Raucci, M. G.,; Guarino, V.,; Ambrosio, L., “Hybrid composite scaffolds prepared by sol–gel method for bone regeneration”, Composites Science and Technology 2010, 70, 1861–1868.
161. Guarino, V.,; Causa, F.,; Netti, P. A.,; Ciapetti, G.,; Pagani, S.,; Martini, D.,; Baldini, N.,; Ambrosio, L., “The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2008, 86, 548–557.
162. Venugopal, J.,; Low, S.,; Choon, A. T.,; Kumar, A. B.,; Ramakrishna, S., “Electrospun-modified nanofibrous scaffolds for the mineralization of osteoblast cells”, Journal of Biomedical Materials Research Part A 2008, 85, 408–417.
163. Kim, H.-W.,; Lee, E.-J.,; Kim, H.-E.,; Salih, V.,; Knowles, J. C., “Effect of fluoridation of hydroxyapatite in hydroxyapatite-polycaprolactone composites on osteoblast activity”, Biomaterials 2005, 26, 4395–4404.
164. Choong, C. S.,; Hutmacher, D. W.,; Triffitt, J. T., “Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering”, Tissue Engineering 2006, 12, 2521–2531.
165. Yeong, W.-Y.,; Chua, C.-K.,; Leong, K.-F.,; Chandrasekaran, M., “Rapid prototyping in tissue engineering: challenges and potential”, Trends in Biotechnology 2004, 22, 643–652.
166. Sachlos, E.,; Czernuszka, J., “Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds”, Eur Cell Mater 2003, 5, 39–40.
167. Wiria, F.,; Leong, K.,; Chua, C.,; Liu, Y., “Poly-ϵ-caprolactone/hydroxyapatite for tissue engineering scaffold fabrication via selective laser sintering”, Acta Biomaterialia 2007, 3, 1–12.
168. Eosoly, S.,; Brabazon, D.,; Lohfeld, S.,; Looney, L., “Selective laser sintering of hydroxyapatite/poly-ϵ-caprolactone scaffolds”, Acta Biomaterialia 2010, 6, 2511–2517.
169. Eosoly, S.,; Vrana, N. E.,; Lohfeld, S.,; Hindie, M.,; Looney, L., “Interaction of cell culture with composition effects on the mechanical properties of polycaprolactone-hydroxyapatite scaffolds fabricated via selective laser sintering (SLS)”, Materials Science and Engineering: C 2012, 32, 2250–2257.
170. Hong, S.-J.,; Jeong, I.,; Noh, K.-T.,; Yu, H.-S.,; Lee, G.-S.,; Kim, H.-W., “Robotic dispensing of composite scaffolds and in vitro responses of bone marrow stromal cells”, Journal of Materials Science: Materials in Medicine 2009, 20, 1955–1962.
171. Kim, H.-W.,; Knowles, J. C.,; Kim, H.-E., “Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release”, Journal of Materials Science: Materials in Medicine 2005, 16, 189–195.
172. Wang, Y.,; Liu, L.,; Guo, S., “Characterization of biodegradable and cytocompatible nano-hydroxyapatite/polycaprolactone porous scaffolds in degradation in vitro”, Polymer Degradation and Stability 2010, 95, 207–213.
173. Johari, N.,; Fathi, M.,; Golozar, M., “Fabrication, characterization and evaluation of the mechanical properties of poly (ϵ-caprolactone)/nano-fluoridated hydroxyapatite scaffold for bone tissue engineering”, Composites Part B: Engineering 2012, 43, 1671–1675.
174. Pereira, M. M.,; Jones, J. R.,; Hench, L. L., “Bioactive glass and hybrid scaffolds prepared by sol–gel method for bone tissue engineering”, Advances in Applied Ceramics 2013, 104, 35–42.
175. Otadi, M.,; Mohebbi-Kalhori, D., “Evaluate of different bioactive glass on mechanical properties of nanocomposites prepared using electrospinning method”, Procedia Materials Science 2015, 11, 196–201.
176. Tamjid, E.,; Bagheri, R.,; Vossoughi, M.,; Simchi, A., “Effect of particle size on the in vitro bioactivity, hydrophilicity and mechanical properties of bioactive glass-reinforced polycaprolactone composites”, Materials Science and Engineering: C 2011, 31, 1526–1533.
177. Meretoja, V.,; Helminen, A.,; Korventausta, J.,; Haapa-aho, V.,; Seppälä, J.,; Närhi, T., “Crosslinked poly (ε-caprolactone/D, L-lactide)/bioactive glass composite scaffolds for bone tissue engineering”, Journal of Biomedical Materials Research Part A 2006, 77, 261–268.
178. Ji, L.,; Wang, W.,; Jin, D.,; Zhou, S.,; Song, X., “In vitro bioactivity and mechanical properties of bioactive glass nanoparticles/polycaprolactone composites”, Materials Science and Engineering: C 2015, 46, 1–9.
179. Foy, K.,; Riddle, D.,; Schutte, H.,; Latour Jr, R. A., “Interfacial bond hydrolytic stability of calcium phosphate fibers with polycaprolactone polymer”, Soc for Biomaterials 1996, 930–940.
180. Rinehart, J. D.,; Taylor, T.,; Tian, Y.,; Latour, R., “Real-time dissolution measurement of sized and unsized calcium phosphate glass fibers”, Journal of Biomedical Materials Research 1999, 48, 833–840.
181. Jiang, G.,; Evans, M.,; Jones, I.,; Rudd, C.,; Scotchford, C.,; Walker, G., “Preparation of poly (ϵ-caprolactone)/continuous bioglass fibre composite using monomer transfer moulding for bone implant”, Biomaterials 2005, 26, 2281–2288.
182. Elkins, K.,; Nordby, H.,; Janak, C.,; Gray IV, R.,; Bohn, H.,; Baird, D., “Soft elastomers for fused deposition modeling”, In Proc., 8th. Solid Freeform Fabrication Symposium, 1997, pp. 441–448.
183. Korpela, J.,; Kokkari, A.,; Korhonen, H.,; Malin, M.,; Närhi, T.,; Seppälä, J., “Biodegradable and bioactive porous scaffold structures prepared using fused deposition modeling”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2013, 101, 610–619.
184. Poh, P. S.,; Hutmacher, D. W.,; Stevens, M. M.,; Woodruff, M. A., “Fabrication and in vitro characterization of bioactive glass composite scaffolds for bone regeneration”, Biofabrication 2013, 5, 045005.
185. Yun, H.-S.,; Kim, S.-E.,; Park, E. K., “Bioactive glass–poly (ϵ-caprolactone) composite scaffolds with 3 dimensionally hierarchical pore networks”, Materials Science and Engineering: C 2011, 31, 198–205.
186. Jun, I. K.,; Song, J. H.,; Choi, W. Y.,; Koh, Y. H.,; Kim, H. E.,; Kim, H. W., “Porous hydroxyapatite scaffolds coated with bioactive apatite–wollastonite glass–ceramics”, Journal of the American Ceramic Society 2007, 90, 2703–2708.
187. Esfahani, S. R.,; Tavangarian, F.,; Emadi, R., “Nanostructured bioactive glass coating on porous hydroxyapatite scaffold for strength enhancement”, Materials Letters 2008, 62, 3428–3430.
188. Wu, C.,; Ramaswamy, Y.,; Boughton, P.,; Zreiqat, H., “Improvement of mechanical and biological properties of porous CaSiO 3 scaffolds by poly (d, l-lactic acid) modification”, Acta Biomaterialia 2008, 4, 343–353.
189. Miao, X.,; Tan, D. M.,; Li, J.,; Xiao, Y.,; Crawford, R., “Mechanical and biological properties of hydroxyapatite/tricalcium phosphate scaffolds coated with poly (lactic-co-glycolic acid)”, Acta Biomaterialia 2008, 4, 638–645.
190. Roohani-Esfahani, S.-I.,; Nouri-Khorasani, S.,; Lu, Z.,; Appleyard, R.,; Zreiqat, H., “The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite–PCL composites”, Biomaterials 2010, 31, 5498–5509.
191. Roohani-Esfahani, S.,; Nouri-Khorasani, S.,; Lu, Z.,; Appleyard, R.,; Zreiqat, H., “Effects of bioactive glass nanoparticles on the mechanical and biological behavior of composite coated scaffolds”, Acta Biomaterialia 2011, 7, 1307–1318.
192. Hum, J.,; Luczynski, K.,; Nooeaid, P.,; Newby, P.,; Lahayne, O.,; Hellmich, C.,; Boccaccini, A., “Stiffness improvement of 45S5 bioglass®-based scaffolds through natural and synthetic biopolymer coatings: An ultrasonic study”, Strain 2013, 49, 431–439.
193. Kim, H. W.,; Kim, H. E.,; Knowles, J. C., “Production and potential of bioactive glass nanofibers as a next-generation biomaterial”, Advanced Functional Materials 2006, 16, 1529–1535.
194. Lee, H.-H.,; Yu, H.-S.,; Jang, J.-H.,; Kim, H.-W., “Bioactivity improvement of poly (ϵ-caprolactone) membrane with the addition of nanofibrous bioactive glass”, Acta Biomaterialia 2008, 4, 622–629.
195. Silva, C.,; Luz, G.,; Gamboa-martÍnez, T. C.,; Mano, J. F.,; Gómez Ribelles, J. L.,; Gómez-tejedor, J. A., “Poly (ϵ-caprolactone) electrospun scaffolds filled with nanoparticles. Production and optimization according to Taguchi's methodology”, Journal of Macromolecular Science, Part B 2014, 53, 781–799.
196. Lin, H.-M.,; Lin, Y.-H.,; Hsu, F.-Y., “Preparation and characterization of mesoporous bioactive glass/polycaprolactone nanofibrous matrix for bone tissues engineering”, Journal of Materials Science: Materials in Medicine 2012, 23, 2619–2630.
197. Ren, J.,; Blackwood, K. A.,; Doustgani, A.,; Poh, P. P.,; Steck, R.,; Stevens, M. M.,; Woodruff, M. A., “Melt-electrospun polycaprolactone strontium-substituted bioactive glass scaffolds for bone regeneration”, Journal of Biomedical Materials Research Part A 2014, 102, 3140–3153.
198. Mouriño, V.,; Cattalini, J. P.,; Roether, J. A.,; Dubey, P.,; Roy, I.,; Boccaccini, A. R., “Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering”, Expert Opinion on Drug Delivery 2013, 10, 1353–1365.
199. Kim, H. W.,; Knowles, J. C.,; Kim, H. E., “Effect of biphasic calcium phosphates on drug release and biological and mechanical properties of poly (ε-caprolactone) composite membranes”, Journal of Biomedical Materials Research Part A 2004, 70, 467–479.
200. Mondal, T.,; Sunny, M.,; Khastgir, D.,; Varma, H.,; Ramesh, P., “Poly (l-lactide-co-Є caprolactone) microspheres laden with bioactive glass-ceramic and alendronate sodium as bone regenerative scaffolds”, Materials Science and Engineering: C 2012, 32, 697–706.
201. Kim, H. W.,; Lee, E. J.,; Jun, I. K.,; Kim, H. E.,; Knowles, J. C., “Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2005, 75, 34–41.
202. Gamble, J. L., “Chemical anatomy, physiology and pathology of extracellular fluid: a lecture syllabus”; Harvard University Press, 1954.
203. Cannillo, V.,; Chiellini, F.,; Fabbri, P.,; Sola, A., “Production of Bioglass® 45S5–Polycaprolactone composite scaffolds via salt-leaching”, Composite Structures 2010, 92, 1823–1832.
204. Ródenas-Rochina, J.,; Ribelles, J. L. G.,; Lebourg, M., “Comparative study of PCL-HAp and PCL-bioglass composite scaffolds for bone tissue engineering”, Journal of Materials Science: Materials in Medicine 2013, 24, 1293–1308.
205. Li, X.,; Shi, J.,; Dong, X.,; Zhang, L.,; Zeng, H., “A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior”, Journal of Biomedical Materials Research Part A 2008, 84, 84–91.
206. Melchels, F. P.,; Feijen, J.,; Grijpma, D. W., “A review on stereolithography and its applications in biomedical engineering”, Biomaterials 2010, 31, 6121–6130.
207. Elomaa, L.,; Kokkari, A.,; Närhi, T.,; Seppälä, J. V., “Porous 3D modeled scaffolds of bioactive glass and photocrosslinkable poly (ϵ-caprolactone) by stereolithography”, Composites Science and Technology 2013, 74, 99–106.
208. Oh, C.-H.,; Hong, S.-J.,; Jeong, I.,; Yu, H.-S.,; Jegal, S.-H.,; Kim, H.-W., “Development of robotic dispensed bioactive scaffolds and human adipose–derived stem cell culturing for bone tissue engineering”, Tissue Engineering Part C: Methods 2009, 16, 561–571.
209. Allo, B. A.,; Rizkalla, A. S.,; Mequanint, K., “Synthesis and electrospinning of ϵ-polycaprolactone-bioactive glass hybrid Biomaterials via a sol-gel process”, Langmuir 2010, 26, 18340–18348.
210. Jo, J. H.,; Lee, E. J.,; Shin, D. S.,; Kim, H. E.,; Kim, H. W.,; Koh, Y. H.,; Jang, J. H., “In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly (ϵ-caprolactone) composite materials”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2009, 91, 213–220.
211. Meretoja, V. V.,; Tirri, T.,; Malin, M.,; Seppälä, J. V.,; Närhi, T. O., “Ectopic bone formation in and soft-tissue response to P (CL/DLLA)/bioactive glass composite scaffolds”, Clinical Oral Implants Research 2014, 25, 159–164.
212. Erdemli, O.,; Captug, O.,; Bilgili, H.,; Orhan, D.,; Tezcaner, A.,; Keskin, D., “In vitro and in vivo evaluation of the effects of demineralized bone matrix or calcium sulfate addition to polycaprolactone–bioglass composites”, Journal of Materials Science: Materials in Medicine 2010, 21, 295–308.
213. Knowles, J. C., “Phosphate based glasses for biomedical applications”, Journal of Materials Chemistry 2003, 13, 2395–2401.
214. Ahmed, I.,; Lewis, M.,; Olsen, I.,; Knowles, J., “Phosphate glasses for tissue engineering: part 1. Processing and characterisation of a ternary-based P 2 O 5–CaO–Na 2 O glass system”, Biomaterials 2004, 25, 491–499.
215. Neel, E. A. A.,; Pickup, D. M.,; Valappil, S. P.,; Newport, R. J.,; Knowles, J. C., “Bioactive functional materials: A perspective on phosphate-based glasses”, Journal of Materials Chemistry 2009, 19, 690–701.
216. Prabhakar, R. L.,; Brocchini, S.,; Knowles, J. C., “Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass-polycaprolactone composites”, Biomaterials 2005, 26, 2209–2218.
217. Mohammadi, M. S.,; Ahmed, I.,; Marelli, B.,; Rudd, C.,; Bureau, M. N.,; Nazhat, S. N., “Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations”, Acta Biomaterialia 2010, 6, 3157–3168.
218. Kouhi, M.,; Morshed, M.,; Varshosaz, J.,; Fathi, M. H., “Poly (ϵ-caprolactone) incorporated bioactive glass nanoparticles and simvastatin nanocomposite nanofibers: Preparation, characterization and in vitro drug release for bone regeneration applications”, Chemical Engineering Journal 2013, 228, 1057–1065.
219. Ahmed, I.,; Parsons, A.,; Palmer, G.,; Knowles, J.,; Walker, G.,; Rudd, C., “Weight loss, ion release and initial mechanical properties of a binary calcium phosphate glass fibre/PCL composite”, Acta Biomaterialia 2008, 4, 1307–1314.
220. Rich, J.,; Jaakkola, T.,; Tirri, T.,; Närhi, T.,; Yli-Urpo, A.,; Seppälä, J., “In vitro evaluation of poly (ϵ-caprolactone-co-DL-lactide)/bioactive glass composites”, Biomaterials 2002, 23, 2143–2150.
221. Larrañaga, A.,; Aldazabal, P.,; Martin, F.,; Sarasua, J., “Hydrolytic degradation and bioactivity of lactide and caprolactone based sponge-like scaffolds loaded with bioactive glass particles”, Polymer Degradation and Stability 2014, 110, 121–128.
222. Chouzouri, G.,; Xanthos, M., “In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers”, Acta Biomaterialia 2007, 3, 745–756.
223. Fabbri, P.,; Cannillo, V.,; Sola, A.,; Dorigato, A.,; Chiellini, F., “Highly porous polycaprolactone-45S5 Bioglass® scaffolds for bone tissue engineering”, Composites Science and Technology 2010, 70, 1869–1878.
224. Lei, B.,; Shin, K.-H.,; Noh, D.-Y.,; Jo, I.-H.,; Koh, Y.-H.,; Kim, H.-E.,; Kim, S. E., “Sol–gel derived nanoscale bioactive glass (NBG) particles reinforced poly (ϵ-caprolactone) composites for bone tissue engineering”, Materials Science and Engineering: C 2013, 33, 1102–1108.
225. Lei, B.,; Shin, K. H.,; Noh, D. Y.,; Koh, Y. H.,; Choi, W. Y.,; Kim, H. E., “Bioactive glass microspheres as reinforcement for improving the mechanical properties and biological performance of poly (ϵ-caprolactone) polymer for bone tissue regeneration”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2012, 100, 967–975.
226. Larrañaga, A.,; Diamanti, E.,; Rubio, E.,; Palomares, T.,; Alonso-Varona, A.,; Aldazabal, P.,; Martin, F.,; Sarasua, J., “A study of the mechanical properties and cytocompatibility of lactide and caprolactone based scaffolds filled with inorganic bioactive particles”, Materials Science and Engineering: C 2014, 42, 451–460.
227. Kang, Y.,; Yin, G.,; Yuan, Q.,; Yao, Y.,; Huang, Z.,; Liao, X.,; Yang, B.,; Liao, L.,; Wang, H., “Preparation of poly (l-lactic acid)/β-tricalcium phosphate scaffold for bone tissue engineering without organic solvent”, Materials Letters 2008, 62, 2029–2032.
228. Mondrinos, M. J.,; Dembzynski, R.,; Lu, L.,; Byrapogu, V. K.,; Wootton, D. M.,; Lelkes, P. I.,; Zhou, J., “Porogen-based solid freeform fabrication of polycaprolactone–calcium phosphate scaffolds for tissue engineering”, Biomaterials 2006, 27, 4399–4408.
229. Martínez-Vázquez, F. J.,; Perera, F. H.,; Miranda, P.,; Pajares, A.,; Guiberteau, F., “Improving the compressive strength of bioceramic robocast scaffolds by polymer infiltration”, Acta Biomaterialia 2010, 6, 4361–4368.
230. Kim, M. S.,; Kim, G. H., “Highly porous electrospun 3D polycaprolactone/β-TCP biocomposites for tissue regeneration”, Materials Letters 2014, 120, 246–250.
231. Guarino, V.,; Ambrosio, L., “The synergic effect of polylactide fiber and calcium phosphate particle reinforcement in poly ϵ-caprolactone-based composite scaffolds”, Acta Biomaterialia 2008, 4, 1778–1787.
232. Xue, W.,; Bandyopadhyay, A.,; Bose, S., “Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2009, 91, 831–838.
233. Shin, M.,; Yoshimoto, H.,; Vacanti, J. P., “In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold”, Tissue Engineering 2004, 10, 33–41.
234. Badami, A. S.,; Kreke, M. R.,; Thompson, M. S.,; Riffle, J. S.,; Goldstein, A. S., “Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly (lactic acid) substrates”, Biomaterials 2006, 27, 596–606.
235. Takeuchi, A.,; Ohtsuki, C.,; Miyazaki, T.,; Tanaka, H.,; Yamazaki, M.,; Tanihara, M., “Deposition of bone-like apatite on silk fiber in a solution that mimics extracellular fluid”, Journal of Biomedical Materials Research Part A 2003, 65, 283–289.
236. Murphy, W. L.,; Kohn, D. H.,; Mooney, D. J., “Growth of continuous bonelike mineral within porous poly (lactide-co-glycolide) scaffolds in vitro”, Journal of Biomedical Materials Research 2000, 50, 50–58.
237. Yang, F.,; Wolke, J.,; Jansen, J., “Biomimetic calcium phosphate coating on electrospun poly (ϵ-caprolactone) scaffolds for bone tissue engineering”, Chemical Engineering Journal 2008, 137, 154–161.
238. Poh, P. S.,; Hutmacher, D. W.,; Holzapfel, B. M.,; Solanki, A. K.,; Stevens, M. M.,; Woodruff, M. A., “In vitro and in vivo bone formation potential of surface calcium phosphate-coated polycaprolactone and polycaprolactone/bioactive glass composite scaffolds”, Acta Biomaterialia 2016, 30, 319–333.
239. Beşkardeş, I. G.,; Gümüşderelioğlu, M., “Biomimetic apatite-coated PCL scaffolds: effect of surface nanotopography on cellular functions”, Journal of Bioactive and Compatible Polymers 2009, 24, 507–524.
240. Mavis, B.,; Demirtaş, T. T.,; Gümüşderelioğlu, M.,; Gündüz, G.,; Çolak, Ü., “Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate”, Acta Biomaterialia 2009, 5, 3098–3111.
241. Li, X.,; Xie, J.,; Yuan, X.,; Xia, Y., “Coating electrospun poly (ϵ-caprolactone) fibers with gelatin and calcium phosphate and their use as biomimetic scaffolds for bone tissue engineering”, Langmuir 2008, 24, 14145–14150.
242. Holmbom, J.,; Södergård, A.,; Ekholm, E.,; Märtson, M.,; Kuusilehto, A.,; Saukko, P.,; Penttinen, R., “Long-term evaluation of porous poly (ε-caprolactone-co-L-lactide) as a bone-filling material”, Journal of Biomedical Materials Research Part A 2005, 75, 308–315.
243. Patlolla, A.,; Arinzeh, T. L., “Evaluating apatite formation and osteogenic activity of electrospun composites for bone tissue engineering”, Biotechnology and Bioengineering 2014, 111, 1000–1017.
244. Polini, A.,; Pisignano, D.,; Parodi, M.,; Quarto, R.,; Scaglione, S., “Osteoinduction of human mesenchymal stem cells by bioactive composite scaffolds without supplemental osteogenic growth factors”, PloS One 2011, 6, e26211.
245. Rajzer, I.,; Menaszek, E.,; Kwiatkowski, R.,; Planell, J. A.,; Castano, O., “Electrospun gelatin/poly (ϵ-caprolactone) fibrous scaffold modified with calcium phosphate for bone tissue engineering”, Materials Science and Engineering: C 2014, 44, 183–190.
246. Moroni, L.,; De Wijn, J.,; Van Blitterswijk, C., “3D fiber-deposited scaffolds for tissue engineering: influence of pores geometry and architecture on dynamic mechanical properties”, Biomaterials 2006, 27, 974–985.
247. Leong, K.,; Cheah, C.,; Chua, C., “Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs”, Biomaterials 2003, 24, 2363–2378.
248. Sharaf, B.,; Faris, C. B.,; Abukawa, H.,; Susarla, S. M.,; Vacanti, J. P.,; Kaban, L. B.,; Troulis, M. J., “Three-dimensionally printed polycaprolactone and β-tricalcium phosphate scaffolds for bone tissue engineering: An in vitro study”, Journal of Oral and Maxillofacial Surgery 2012, 70, 647–656.
249. Choong, C.,; Triffitt, J.,; Cui, Z., “Polycaprolactone scaffolds for bone tissue engineering: effects of a calcium phosphate coating layer on osteogenic cells”, Food and Bioproducts Processing 2004, 82, 117–125.
250. Lei, Y.,; Rai, B.,; Ho, K.,; Teoh, S., “In vitro degradation of novel bioactive polycaprolactone—20% tricalcium phosphate composite scaffolds for bone engineering”, Materials Science and Engineering: C 2007, 27, 293–298.
251. Zhou, Y.,; Hutmacher, D. W.,; Varawan, S. L.,; Lim, T. M., “In vitro bone engineering based on polycaprolactone and polycaprolactone–tricalcium phosphate composites”, Polymer International 2007, 56, 333–342.
252. Schantz, J.-T.,; Brandwood, A.,; Hutmacher, D. W.,; Khor, H. L.,; Bittner, K., “Osteogenic differentiation of mesenchymal progenitor cells in computer designed fibrin-polymer-ceramic scaffolds manufactured by fused deposition modeling”, Journal of Materials Science: Materials in Medicine 2005, 16, 807–819.
253. Rai, B.,; Lin, J. L.,; Lim, Z. X.,; Guldberg, R. E.,; Hutmacher, D. W.,; Cool, S. M., “Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL–TCP scaffolds”, Biomaterials 2010, 31, 7960–7970.
254. Zizak, I.,; Roschger, P.,; Paris, O.,; Misof, B.,; Berzlanovich, A.,; Bernstorff, S.,; Amenitsch, H.,; Klaushofer, K.,; Fratzl, P., “Characteristics of mineral particles in the human bone/cartilage interface”, Journal of Structural Biology 2003, 141, 208–217.
255. Sasaki, N.,; Sudoh, Y., “X-ray pole figure analysis of apatite crystals and collagen molecules in bone”, Calcified Tissue International 1997, 60, 361–367.
256. Erisken, C.,; Kalyon, D. M.,; Wang, H., “Functionally graded electrospun polycaprolactone and β-tricalcium phosphate nanocomposites for tissue engineering applications”, Biomaterials 2008, 29, 4065–4073.
257. Paik, D.-H.,; Jeong, K.-Y.,; Moon, S.-K.,; Oh, M.-J.,; Ryu, T.-K.,; Kim, S.-E.,; Kim, J.-H.,; Park, J.-H.,; Choi, S.-W., “A facile method for preparation of polycaprolactone/tricalcium phosphate fibrous matrix with a gradient mineral content”, Colloids and Surfaces A: Physicochemical and Engineering Aspects 2013, 429, 134–141.
258. Porter, J. R.,; Ruckh, T. T.,; Popat, K. C., “Bone tissue engineering: A review in bone biomimetics and drug delivery strategies”, Biotechnology Progress 2009, 25, 1539–1560.
259. Rai, B.,; Teoh, S.-H.,; Ho, K.,; Hutmacher, D.,; Cao, T.,; Chen, F.,; Yacob, K., “The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds”, Biomaterials 2004, 25, 5499–5506.
260. Rai, B.,; Teoh, S.-H.,; Hutmacher, D.,; Cao, T.,; Ho, K., “Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2”, Biomaterials 2005, 26, 3739–3748.
261. Miyai, T.,; Ito, A.,; Tamazawa, G.,; Matsuno, T.,; Sogo, Y.,; Nakamura, C.,; Yamazaki, A.,; Satoh, T., “Antibiotic-loaded poly-ϵ-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis”, Biomaterials 2008, 29, 350–358.
262. Rai, B.,; Ho, K. H.,; Lei, Y.,; Si-Hoe, K.-M.,; Teo, C.-M. J.,; bin Yacob, K.,; Chen, F.,; Ng, F.-C.,; Teoh, S. H., “Polycaprolactone-20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study”, Journal of Oral and Maxillofacial Surgery 2007, 65, 2195–2205.
263. Khojasteh, A.,; Behnia, H.,; Hosseini, F. S.,; Dehghan, M. M.,; Abbasnia, P.,; Abbas, F. M., “The effect of PCL-TCP scaffold loaded with mesenchymal stem cells on vertical bone augmentation in dog mandible: A preliminary report”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2013, 101, 848–854.
264. Li, Y.,; Wu, Z.-g.,; Li, X.-k.,; Guo, Z.,; Wu, S.-h.,; Zhang, Y.-q.,; Shi, L.,; Teoh, S.-h.,; Liu, Y.-c.,; Zhang, Z.-y., “A polycaprolactone-tricalcium phosphate composite scaffold as an autograft-free spinal fusion cage in a sheep model”, Biomaterials 2014, 35, 5647–5659.
265. Shao, X.,; Goh, J. C.,; Hutmacher, D. W.,; Lee, E. H.,; Zigang, G., “Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model”, Tissue Engineering 2006, 12, 1539–1551.
266. Lohfeld, S.,; Cahill, S.,; Barron, V.,; McHugh, P.,; Dürselen, L.,; Kreja, L.,; Bausewein, C.,; Ignatius, A., “Fabrication, mechanical and in vivo performance of polycaprolactone/tricalcium phosphate composite scaffolds”, Acta Biomaterialia 2012, 8, 3446–3456.
267. Konopnicki, S.,; Sharaf, B.,; Resnick, C.,; Patenaude, A.,; Pogal-Sussman, T.,; Hwang, K.-G.,; Abukawa, H.,; Troulis, M. J., “Tissue-engineered bone with 3-dimensionally printed β-tricalcium phosphate and polycaprolactone scaffolds and early implantation: An in vivo pilot study in a porcine mandible model”, Journal of Oral and Maxillofacial Surgery 2015, 73, 1016. e1–1016. e11.
268. Ho, S. T. B.,; Hutmacher, D. W.,; Ekaputra, A. K.,; Hitendra, D.,; Hui, J. H., “The evaluation of a biphasic osteochondral implant coupled with an electrospun membrane in a large animal model”, Tissue Engineering Part A 2009, 16, 1123–1141.
269. Oyane, A.,; Uchida, M.,; Yokoyama, Y.,; Choong, C.,; Triffitt, J.,; Ito, A., “Simple surface modification of poly (ε-caprolactone) to induce its apatite-forming ability”, Journal of Biomedical Materials Research Part A 2005, 75, 138–145.
270. Oyane, A.,; Uchida, M.,; Choong, C.,; Triffitt, J.,; Jones, J.,; Ito, A., “Simple surface modification of poly (ϵ-caprolactone) for apatite deposition from simulated body fluid”, Biomaterials 2005, 26, 2407–2413.
271. Fu, Y.,; Xu, H.,; Bai, S.,; Qiu, D.,; Sun, J.,; Wang, Z.,; Zhang, X., “Fabrication of a stable polyelectrolyte/Au nanoparticles multilayer film”, Macromolecular Rapid Communications 2002, 23, 256–259.
272. Kwak, K.-A.,; Jyoti, M. A.,; Song, H.-Y., “In vitro and in vivo studies of three dimensional porous composites of biphasic calcium phosphate/poly ϵ-caprolactone: Effect of bio-functionalization for bone tissue engineering”, Applied Surface Science 2014, 301, 307–314.
273. Kwak, K.-A.,; Kim, Y.-H.,; Kim, M.,; Lee, B.-T.,; Song, H.-Y., “Bio-functionalization of polycaprolactone infiltrated BCP scaffold with silicon and fibronectin enhances osteoblast activity in vitro”, Applied Surface Science 2013, 279, 13–22.
274. Patlolla, A.,; Collins, G.,; Arinzeh, T. L., “Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration”, Acta Biomaterialia 2010, 6, 90–101.
275. Zhou, Y.,; Chen, F.,; Ho, S. T.,; Woodruff, M. A.,; Lim, T. M.,; Hutmacher, D. W., “Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts”, Biomaterials 2007, 28, 814–824.
276. Yefang, Z.,; Hutmacher, D.,; Varawan, S.-L.,; Meng, L. T., “Comparison of human alveolar osteoblasts cultured on polymer-ceramic composite scaffolds and tissue culture plates”, International Journal of Oral and Maxillofacial Surgery 2007, 36, 137–145.
277. Yeo, A.,; Sju, E.,; Rai, B.,; Teoh, S. H., “Customizing the degradation and load-bearing profile of 3D polycaprolactone-tricalcium phosphate scaffolds under enzymatic and hydrolytic conditions”, Journal of Biomedical Materials Research Part B: Applied Biomaterials 2008, 87, 562–569.
278. Doyle, H.,; Lohfeld, S.,; McHugh, P., “Evaluating the effect of increasing ceramic content on the mechanical properties, material microstructure and degradation of selective laser sintered polycaprolactone/β-tricalcium phosphate materials”, Medical Engineering & Physics 2015, 37, 767–776.